Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
暂无分享,去创建一个
Miguel Prudêncio | Jon Clardy | M. Mota | J. Clardy | M. Prudêncio | E. Derbyshire | Maria M. Mota | Emily R. Derbyshire
[1] J. Clardy,et al. Characterization of Plasmodium Liver Stage Inhibition by Halofuginone , 2012, ChemMedChem.
[2] M. Mota,et al. A toolbox to study liver stage malaria. , 2011, Trends in parasitology.
[3] M. Aepfelbacher,et al. Organelle segregation into Plasmodium liver stage merozoites , 2011, Cellular microbiology.
[4] M. Mota,et al. The Next Opportunity in Anti-Malaria Drug Discovery: The Liver Stage , 2011, PLoS pathogens.
[5] X. Su,et al. Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets , 2011, Science.
[6] François Nosten,et al. The reality of using primaquine , 2010, Malaria Journal.
[7] Bruce Russell,et al. Spiroindolones, a Potent Compound Class for the Treatment of Malaria , 2010, Science.
[8] A. Hasnat,et al. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study. , 2010, Clinical therapeutics.
[9] James R. Brown,et al. Thousands of chemical starting points for antimalarial lead identification , 2010, Nature.
[10] Anang A. Shelat,et al. Chemical genetics of Plasmodium falciparum , 2010, Nature.
[11] A. Azad,et al. Transcriptional Analysis of the Pre-Erythrocytic Stages of the Rodent Malaria Parasite, Plasmodium yoelii , 2010, PloS one.
[12] Yingyao Zhou,et al. A Systems-Based Analysis of Plasmodium vivax Lifecycle Transcription from Human to Mosquito , 2010, PLoS neglected tropical diseases.
[13] Robert W. Sauerwein,et al. Visualisation and Quantitative Analysis of the Rodent Malaria Liver Stage by Real Time Imaging , 2009, PloS one.
[14] L. Rénia,et al. A pre-emptive strike against malaria's stealthy hepatic forms , 2009, Nature Reviews Drug Discovery.
[15] P. Koehler,et al. History of Methysergide in Migraine , 2008, Cephalalgia : an international journal of headache.
[16] Peter G. Schultz,et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen , 2008, Proceedings of the National Academy of Sciences.
[17] Nicholas J White,et al. Vivax malaria: neglected and not benign. , 2007, The American journal of tropical medicine and hygiene.
[18] R. Sauerwein,et al. A Plant-Derived Morphinan as a Novel Lead Compound Active against Malaria Liver Stages , 2006, PLoS medicine.
[19] D. Wirth,et al. High-Throughput Plasmodium falciparum Growth Assay for Malaria Drug Discovery , 2006, Antimicrobial Agents and Chemotherapy.
[20] Ana Rodriguez,et al. The silent path to thousands of merozoites: the Plasmodium liver stage , 2006, Nature Reviews Microbiology.
[21] V. Roche. The chemically elegant proton pump inhibitors. , 2006, American journal of pharmaceutical education.
[22] T. Golub,et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.
[23] Jun O. Liu,et al. A clinical drug library screen identifies astemizole as an antimalarial agent , 2006, Nature chemical biology.
[24] S. Kappe,et al. Malaria liver stage culture: in vitro veritas? , 2006, The American journal of tropical medicine and hygiene.
[25] Elisabetta Pizzi,et al. Genome-wide identification of genes upregulated at the onset of gametocytogenesis in Plasmodium falciparum. , 2005, Molecular and biochemical parasitology.
[26] J. Baird,et al. Effectiveness of antimalarial drugs. , 2005, The New England journal of medicine.
[27] G. Wilkinson,et al. Drug metabolism and variability among patients in drug response. , 2005, The New England journal of medicine.
[28] S. Hoffman,et al. Primaquine therapy for malaria. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] Patricia De la Vega,et al. Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle , 2003, Science.
[30] F. Cohen,et al. Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray , 2003, Genome Biology.
[31] Jonathan E. Allen,et al. Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.
[32] D. Kyle,et al. Efficacy of Proton Pump Inhibitor Drugs against Plasmodium falciparum In Vitro and Their Probable Pharmacophores , 2002, Antimicrobial Agents and Chemotherapy.
[33] J. Sachs,et al. The economic and social burden of malaria , 2002, Nature.
[34] Ogobara K. Doumbo,et al. The pathogenic basis of malaria , 2002, Nature.
[35] R. Rosenberg,et al. Continuous in vitro propagation of the malaria parasite Plasmodium vivax. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Miners,et al. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. , 1993, British journal of clinical pharmacology.
[37] W. Trager,et al. Human malaria parasites in continuous culture. , 1976, Science.
[38] H. Notopuro,et al. Glucose-6-phosphate dehydrogenase deficiency. , 1972, Paediatrica Indonesiana.
[39] L. Scott,et al. Telmisartan , 2012, Drugs.
[40] Q. Bassat,et al. Defying malaria: Fathoming severe Plasmodium vivax disease , 2011, Nature Medicine.
[41] T. Andersson,et al. Stereoselective Disposition of Proton Pump Inhibitors , 2008, Clinical drug investigation.
[42] T. Andersson,et al. Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of Omeprazole , 2001, Clinical pharmacokinetics.